Inadequate Antimicrobial Treatment of Infections
Abstract
Study objective To evaluate the relationship between inadequate antimicrobial treatment of infections (both community-acquired and nosocomial infections) and hospital mortality for patients requiring ICU admission.Design Prospective cohort study.Setting Barnes-Jewish Hospital, a university-affiliated urban teaching hospital.Patients Two thousand consecutive patients requiring admission to the medical or surgical ICU.Interventions Prospective patient surveillance and data collection.Measurements and results One hundred sixty-nine (8.5%) infected patients received inadequate antimicrobial treatment of their infections. This represented 25.8% of the 655 patients assessed to have either community-acquired or nosocomial infections. The occurrence of inadequate antimicrobial treatment of infection was most common among patients with nosocomial infections, which developed after treatment of a community-acquired infection (45.2%), followed by patients with nosocomial infections alone (34.3%) and patients with community-acquired infections alone (17.1%) (p < 0.001). Multiple logistic regression analysis, using only the cohort of infected patients (n = 655), demonstrated that the prior administration of antibiotics (adjusted odds ratio [OR], 3.39; 95% confidence interval [CI], 2.88 to 4.23; p < 0.001), presence of a bloodstream infection (adjusted OR, 1.88; 95% CI, 1.52 to 2.32; p = 0.003), increasing acute physiology and chronic health evaluation (APACHE) II scores (adjusted OR, 1.04; 95% CI, 1.03 to 1.05; p = 0.002), and decreasing patient age (adjusted OR, 1.01; 95% CI, 1.01 to 1.02; p = 0.012) were independently associated with the administration of inadequate antimicrobial treatment. The hospital mortality rate of infected patients receiving inadequate antimicrobial treatment (52.1%) was statistically greater than the hospital mortality rate of the remaining patients in the cohort (n = 1,831) without this risk factor (12.2%) (relative risk [RR], 4.26; 95% CI, 3.52 to 5.15; p < 0.001). Similarly, the infection-related mortality rate for infected patients receiving inadequate antimicrobial treatment (42.0%) was significantly greater than the infection-related mortality rate of infected patients receiving adequate antimicrobial treatment (17.7%) (RR, 2.37; 95% CI, 1.83 to 3.08; p < 0.001). Using a logistic regression model, inadequate antimicrobial treatment of infection was found to be the most important independent determinant of hospital mortality for the entire patient cohort (adjusted OR, 4.27; 95% CI, 3.35 to 5.44; p < 0.001). The other identified independent determinants of hospital mortality included the number of acquired organ system derangements, use of vasopressor agents, the presence of an underlying malignancy, increasing APACHE II scores, increasing age, and having a nonsurgical diagnosis at the time of ICU admission.Conclusions Inadequate treatment of infections among patients requiring ICU admission appears to be an important determinant of hospital mortality. These data suggest that clinical efforts aimed at reducing the occurrence of inadequate antimicrobial treatment could improve the outcomes of critically ill patients. Additionally, prior antimicrobial therapy should be recognized as an important risk factor for the administration of inadequate antimicrobial treatment among ICU patients with clinically suspected infections.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Prompt identification of invasive candidiasis through risk factor analysis and diagnostic assays is a key factor affecting sepsis-related mortality.
“The importance of prompt identification of IC through a combination of risk factor analysis and diagnostic assays has been demonstrated to be a key factor affecting sepsis-related mortality.[32][33][34][35][36][37][38][39][40][41]”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [32]
Cites
Bone, R. C., BALK, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1644 · Cited by 13,192 · see citing works
CDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,665 · see citing works
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,779 · see citing works
The APACHE III Prognostic System
Knaus, W. A., Wagner, D. P., Draper, E. A., Zimmerman, J. E., Bergner, M., BASTOS, P. G., Sirio, C., Murphy, D. J., Lotring, T., Damiano, A., et al. (1991) · CHEST Journal · doi:10.1378/chest.100.6.1619 · Cited by 3,524 · see citing works
The APACHE III Prognostic System
Teres, D., & Lemeshow, S. A. (1992) · CHEST Journal · doi:10.1378/chest.102.6.1919b · Cited by 2,880 · see citing works
The Prevalence of Nosocomial Infection in Intensive Care Units in Europe
Vincent, J. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,646 · see citing works
Herold, B. C. (1998) · JAMA · doi:10.1001/jama.279.8.593 · Cited by 1,412 · see citing works
Weinstein, M. P., Towns, M., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Reller, L. B. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,225 · see citing works
Fagon, J.-Y., Chastre, J. E., Hance, A. J., Montravers, P., Novara, A., & Gibert, C. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90060-3 · Cited by 1,175 · see citing works
The Risk of Determining Risk with Multivariable Models
Concato, J., Feinstein, A. R., & Holford, T. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00009 · Cited by 1,119 · see citing works
Gold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,080 · see citing works
A Computer-Assisted Management Program for Antibiotics and Other Antiinfective Agents
Evans, R. S., Pestotnik, S. L., Classen, D. C., Clemmer, T. P., Weaver, L. K., Orme, J. F., Lloyd, J. F., & Burke, J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801223380406 · Cited by 1,060 · see citing works
Impact of BAL Data on the Therapy and Outcome of Ventilator-Associated Pneumonia
Luna, C. M., Vujacich, P., Niederman, M. S., Vay, C. A., Gherardi, C. R., Matera, J., & Jolly, E. C. (1997) · CHEST Journal · doi:10.1378/chest.111.3.676 · Cited by 915 · see citing works
Incidence, Risk, and Prognosis Factors of Nosocomial Pneumonia in Mechanically Ventilated Patients
Torres, A., Aznar, R., Gatell, J. M., Jiménez, P., González, J., Ferrer, A., Celis, R., & Rodriguez‐Roisin, R. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/142.3.523 · Cited by 913 · see citing works
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887 · see citing works
Ventilator-associated Pneumonia Caused by Potentially Drug-resistant Bacteria
Trouillet, J., Chastre, J. E., Vuagnat, A., Joly‐Guillou, M., Combaux, D., Dombret, M.-C., & Gibert, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9705064 · Cited by 884 · see citing works
Community‐Acquired Pneumonia in Adults: Guidelines for Management
Bartlett, J. G., Breiman, R. F., Mandell, L. A., & File, T. M. (1998) · Clinical Infectious Diseases · doi:10.1086/513953 · Cited by 862 · see citing works
(1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.153.5.8630626 · Cited by 827 · see citing works
Incidence, Risk Factors, and Outcome of Severe Sepsis and Septic Shock in Adults
Brun‐Buisson, C. (1995) · JAMA · doi:10.1001/jama.1995.03530120060042 · Cited by 776 · see citing works
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 755 · see citing works
A COMPUTER-ASSISTED MANAGEMENT PROGRAM FOR ANTIBIOTICS AND OTHER ANTIINFECTIVE AGENTS
Vans, R. S. C. E., Estotnik, S. T. L. P., Lassen, D. A. C. C., Lemmer, T., Eaver, L. I. K. W., Rme, J. A. F. O., Loyd, J. A. F. L., & Urke, J. O. P. B. (1998) · Cited by 692 · see citing works
Celis, R., Torres, A., Gatell, J. M., Almela, M., Rodriguez‐Roisin, R., & Agustí-Vidal, A. (1988) · CHEST Journal · doi:10.1378/chest.93.2.318 · Cited by 685 · see citing works
Álvarez-Lerma, F., & ICU-Acquired Pneumonia Study Group (1996) · Intensive Care Medicine · doi:10.1007/bf01712153 · Cited by 649 · see citing works
Pestotnik, S. L., Classen, D. C., Evans, R. S., & Burke, J. P. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-10-199605150-00004 · Cited by 589 · see citing works
Meinert, C. L. (1986) · DigitalGeorgetown (Georgetown University Library) · doi:10.1093/acprof:oso/9780195035681.001.0001 · Cited by 509 · see citing works
The Influence of Mini-BAL Cultures on Patient Outcomes
Kollef, M. H., & Ward, S. (1998) · CHEST Journal · doi:10.1378/chest.113.2.412 · Cited by 498 · see citing works
Self-citationRello, J., Ausino, V., Ricart, M., Castella, J., & Prats, G. (1993) · CHEST Journal · doi:10.1378/chest.104.4.1230 · Cited by 481 · see citing works
Nosocomial Pneumonia and Mortality Among Patients in Intensive Care Units
Fagon, J.-Y. (1996) · JAMA · doi:10.1001/jama.1996.03530350048033 · Cited by 474 · see citing works
The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
Rello, J., Gallego, M., Mariscal, D., Sonora, R., & Vallés, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9607030 · Cited by 467 · see citing works
The Effect of Late-Onset Ventilator-Associated Pneumonia in Determining Patient Mortality
Kollef, M. H., Silver, P., Murphy, D. M., & Trovillion, E. (1995) · CHEST Journal · doi:10.1378/chest.108.6.1655 · Cited by 401 · see citing works
Self-citationBrun‐Buisson, C., Doyon, F., & Carlet, J. M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810595 · Cited by 340 · see citing works
The Impact of Nosocomial Infections on Patient Outcomes Following Cardiac Surgery
Kollef, M. H., Sharpless, L., Vlasnik, J. J., Pasque, C., Murphy, D. M., & Fraser, V. J. (1997) · CHEST Journal · doi:10.1378/chest.112.3.666 · Cited by 324 · see citing works
Self-citationMontravers, P., Gauzit, R., Muller‐Serieys, C., Marmuse, J., Fichelle, A., & Desmonts, J.-M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.486 · Cited by 322 · see citing works
Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Romero-Vivas, J., Alonso, M. R., Fernandez, C., & Picazo, J. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1417 · Cited by 318 · see citing works
Vidal, F. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440170139015 · Cited by 276 · see citing works
Rubin, D. B., Wiener-Kronish, J. P., Murray, J. F., et al. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114733 · Cited by 271 · see citing works
Patient Selection for Clinical Investigation of Ventilator-Associated Pneumonia
Pingleton, S. K., Fagon, J.-Y., & Leeper, K. V. (1992) · CHEST Journal · doi:10.1378/chest.102.5_supplement_1.553s · Cited by 254 · see citing works
Vallés, J., Leon, C., & Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC) (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.3.387 · Cited by 240 · see citing works
Delay in appropriate therapy ofLegionella pneumonia associated with increased mortality
Heath, C. H., Grove, D. I., & Looke, D. F. M. (1996) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01695659 · Cited by 231 · see citing works
Clinical trials: Design, conduct, and analysis
Rodda, B. E. (1987) · Controlled Clinical Trials · doi:10.1016/0197-2456(87)90162-0 · Cited by 163 · see citing works
Risk factors for infection byPseudomonas aeruginosa in patients with ventilator-associated pneumonia
Rello, J., Ausina, V., Ricart, M., et al. (1994) · Intensive Care Medicine · doi:10.1007/bf01704699 · Cited by 150 · see citing works
Practice parameters for evaluating new fever in critically ill adult patients
O’Grady, N. P., Barie, P. S., Bartlett, J. D., et al. (1998) · Critical Care Medicine · doi:10.1097/00003246-199802000-00046 · Cited by 145 · see citing works
Baraibar, J., Correa, H., Mariscal, D., et al. (1997) · CHEST Journal · doi:10.1378/chest.112.4.1050 · Cited by 135 · see citing works
Burgener-Kairuz, P., Zuber, J. P., Jaunin, P., Buchman, T. G., Billé, J., & Rossier, M. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.8.1902-1907.1994 · Cited by 114 · see citing works
McCabe, K. M., Khan, G., Zhang, Y.-H., et al. (1995) · PEDIATRICS · doi:10.1542/peds.95.2.165 · Cited by 83 · see citing works
Multiple Organ Failure: A Common Problem in Surgical Intensive Care Unit Patients
Livingston, D. H., & Deitch, E. A. (1995) · Annals of Medicine · doi:10.3109/07853899509031931 · Cited by 55 · see citing works
Chang, Y.-C., Huang, C., Wang, S. T., et al. (1997) · Pediatric Neurology · doi:10.1016/s0887-8994(97)00078-7 · Cited by 42 · see citing works
Kollef, M. H., Eisenberg, R., Ohlendorf, M. F., et al. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.4.8887601 · Cited by 41 · see citing works
Self-citationTreatment and Prevention of Nosocomial Pneumonia
Bergogne-Bérézin, E. (1995) · CHEST Journal · doi:10.1378/chest.108.2_supplement.26s · Cited by 33 · see citing works
ANTIBIOTIC RESISTANCE PROBLEMS IN THE CRITICAL CARE UNIT
Mainardi, J., Carlet, J. M., & Acar, J. F. (1998) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70392-4 · Cited by 13 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743 · see citing works
Ibrahim, E. H., Sherman, G., Ward, S., Fraser, V. J., & Kollef, M. H. (2000) · Chest · doi:10.1378/chest.118.1.146 · Cited by 1,779 · see citing works
Self-citationTorres, A., Niederman, M. S., Chastre, J., Ewig, S., Fernandez-Vandellos, P., Hanberger, H., Kollef, M., Li Bassi, G., Luna, C. M., Martin-Loeches, I., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00582-2017 · Cited by 1,387 · see citing works
Self-citationMorrell, M., Fraser, V. J., & Kollef, M. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3640-3645.2005 · Cited by 1,286 · see citing works
Self-citationBouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183 · see citing works
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046 · see citing works
Septic shock attributed to Candida infection: Importance of empiric therapy and source control.
Kollef, M., Micek, S., Hampton, N., Doherty, J. A., & Kumar, A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis305 · Cited by 477 · see citing works
Self-citationBacterial Coinfection in Influenza: A Grand Rounds Review
Chertow, D. S., & Memoli, M. J. (2013) · JAMA · doi:10.1001/jama.2012.194139 · Cited by 390 · see citing works
Jensen, J. U., Hein, L., Lundgren, B., Bestle, M. H., Mohr, T. T., Andersen, M. H., Thornberg, K. J., Løken, J., Steensen, M., Fox, Z., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e31821e8791 · Cited by 356 · see citing works
Culture-Negative Severe Sepsis
Gupta, S., Sakhuja, A., Kumar, G., McGrath, E., Nanchal, R. S., & Kashani, K. B. (2016) · Chest · doi:10.1016/j.chest.2016.08.1460 · Cited by 232 · see citing works
Hranjec, T., Rosenberger, L. H., Swenson, B., Metzger, R., Flohr, T. R., Politano, A. D., Riccio, L. M., Popovsky, K. A., & Sawyer, R. G. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70151-2 · Cited by 231 · see citing works
Kett, D. H., Cano, E., Quartin, A. A., Mangino, J. E., Zervos, M. J., Peyrani, P., Cely, C. M., Ford, K. D., Scerpella, E. G., & Ramirez, J. A. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70314-5 · Cited by 235 · see citing works
Parkins, M. D., Sabuda, D. M., Elsayed, S., & Laupland, K. B. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm212 · Cited by 229 · see citing works
Roberts, J. A., Taccone, F. S., Udy, A. A., Vincent, J.-L., Jacobs, F., & Lipman, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01708-10 · Cited by 226 · see citing works
Schramm, G. E., Johnson, J. A., Doherty, J. A., Micek, S. T., & Kollef, M. H. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000227655.41566.3e · Cited by 145 · see citing works
Self-citationEffect of antifungal therapy timing on mortality in cancer patients with candidemia
Taur, Y., Cohen, N., Dubnow, S., Paskovaty, A., & Seo, S. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00945-09 · Cited by 127 · see citing works
Gene Expression-Based Classifiers Identify Staphylococcus aureus Infection in Mice and Humans
Ahn, S. H., Tsalik, E. L., Cyr, D. D., Zhang, Y., van Velkinburgh, J. C., Langley, R. J., Glickman, S. W., Cairns, C. B., Zaas, A. K., Rivers, E. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0048979 · Cited by 61 · see citing works
Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62 · see citing works
Antimicrobial use in the ICU: Indications and accuracy–an observational trial.
Levin, P. D., Idrees, S., Sprung, C. L., Weissman, C., Weiss, Y., Moses, A. E., & Benenson, S. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.1964 · Cited by 50 · see citing works
Pilot Study of a Web-Based Antibiotic Decision Management Guide
Bochicchio, G. V., Smit, P. A., Moore, R., Bochicchio, K., Auwaerter, P., Johnson, S. B., Scalea, T., & Bartlett, J. G. (2006) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.11.010 · Cited by 41 · see citing works
Furlan, L., Erba, L., Trombetta, L., Sacco, R., Colombo, G., Casazza, G., Solbiati, M., Montano, N., Marta, C., Sbrojavacca, R., et al. (2019) · Internal and Emergency Medicine · doi:10.1007/s11739-018-1955-2 · Cited by 9 · see citing works
- Authors
- Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J.
- Affiliations
- Barnes-Jewish Hospital (US)
- Corresponding author
- Kollef, Marin H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 1999-02
- Volume
- 115
- Issue
- 2
- Pages
- 462-474
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2148706534
- Cited by
- 1,805
- References
- 52
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 25 · 2023: 27 · 2022: 38 · 2021: 33 · 2020: 35 · 2019: 50 · 2018: 49 · 2017: 57 · 2016: 59 · 2015: 69 · 2014: 99 · 2013: 64 · 2012: 93
- FWCI
- 38.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (UR8/CCU715087)
- Topics
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
- Keywords
- nosocomial infections, community-acquired infections, in-hospital mortality, intensive care unit patients, bloodstream infection, prior antibiotic use, APACHE II score, risk factors, infection-related mortality, antimicrobial stewardship, sepsis, surgical site infection, catheter-related infection, mortality prediction model, length of hospital stay
- MeSH terms
- Anti-Infective Agents, Critical Care, Cross Infection, Hospitals, Teaching, Humans, Intensive Care Units, Missouri, Prospective Studies, Risk Factors, Critical Illness, Treatment Outcome, Hospital Mortality, Treatment Failure, Community-Acquired Infections, APACHE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review